The C is for Crank

Komen Foundation Bow to Anti-Choice Pressure, Yanks Planned Parenthood Funds

By Erica C. Barnett January 31, 2012

The Susan G. Komen Foundation---which has been criticized, including by me, for infantilizing women and commercializing the breast-cancer industry, and for focusing exclusively on "curing" breast cancer rather than figuring out causes and preventing it---has withdrawn all financial support for breast-cancer screenings at Planned Parenthood.

Komen's reasoning? Planned Parenthood is under federal investigation (anti-choice Republicans in Congress forced an investigation into the group last year, based on a report by a far-right-wing anti-abortion group), making them ineligible for Komen funds. Conveniently, the new rule happened to coincide precisely with the launch of the investigation.

The group had been under relentless pressure from pro-life groups to stop funding Planned Parenthood, which provides not only breast cancer screenings but annual exams, birth control, STI testing, and, yes, abortions. Additionally, their new public policy director, Karen Handel, is an avowed opponent of choice and of Planned Parenthood in particular.

Apparently, the campaign worked.

But not everyone is taking the funding cut, which will mean thousands fewer cancer screenings for low-income women, lying down.

Take it away, US Sen. Patty Murray:
I am extremely disappointed that politics is once again coming between women and their health care needs. Breast cancer screenings should not be a political issue, and I am very concerned that this decision by the Susan G. Komen for the Cure Foundation will cut women off from the health care providers they rely on for critical preventive care.

At the heart of this issue is the shameful ‘investigation’ of Planned Parenthood by House Republicans trying to score political points and appease their extreme right-wing base. Komen should not allow these sort of partisan games to put women across America at risk.

For an alternative to the Komen kabal, check out Breast Cancer Action.
Show Comments